Kramer P, et al. Intensive care potential of continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1982; 28:28−32. PMID: 7164248
Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368−1377. doi: 10.1056/NEJMoa010307
Rowan KM, et al. Early, goal-directed therapy for septic shock—a patient-level meta-analysis. N Engl J Med 2017; 376:2223−2234. doi: 10.1056/NEJMoa1701380
Gaudry S, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: A systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet 2020; 95:1506−1515. doi: 0.1016/S0140-6736(20)30531-6
Bagshaw SM, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 2020; 383:240−251. doi: 10.1056/NEJMoa2000741
Lins RL, et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: Results of a randomized clinical trial. Nephrol Dial Transplant 2009; 24:512–518. doi: 10.1093/ndt/gfn560
Vinsonneau C, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet 2006; 368:379−385. doi: 10.1016/S0140-6736(06)69111-3
Mehta RL, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154−1163. doi: 10.1046/j.1523-1755.2001.0600031154.x
Schefold JC, et al. The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial. Crit Care 2014; 18:R11. doi: 10.1186/cc13188
Palevsky PM, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:7−20. doi: 10.1056/NEJMoa0802639
McIntyre CW, Rosansky SJ. Starting dialysis is dangerous: How do we balance the risk? Kidney Int 2012; 82:382−387. doi: 10.1038/ki.2012.133